Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia

Overview of attention for article published in Journal of Hematology & Oncology, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 4 X users
patent: 1 patent

facebook: 1 Facebook page

Readers on

mendeley: 69 Mendeley

Summary X Patents Facebook

So far, Altmetric has seen 1 patent that references this research output.

ANTI-CD79B×CD3 BISPECIFIC ANTIBODY AND USE THEREOF

Application WO-2023011338-A1

World Intellectual Property Organisation (WIPO)